Published

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM

No abstract availability was recorded for this entry.

Open source BibTeX RIS

Bibliographic context

Journal: BJPsych Open
Date: 2026-05-01
Source: Crossref
DOI: 10.1192/bjo.2026.12000
PubMed: 42125778

Authors

Beidas Zeina Ragnhildstveit Anya Blackman Adam Anderson Thomas Fewster Emily Syed Omer A.Sobolenko Valentyne Kanca Ismail Kaan Son Tatiana Farb Norman Petranker Rotem

Watch author

Derived topics and classifications

psilocybin Depression Microdosing Clinical Trial Clinical Trial

Citation graph

1 referenced DOI found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1192/bjo.2025.10968

Indexed papers citing this DOI

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM2026-05-01

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30 A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27 Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?Journal of Science Policy & Governance · 2026-07-02 THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14 A Pilot Mechanistic Study of Psilocybin-Assisted Therapy as a Treatment for DepressionClinicalTrials.gov · 2026-05-20 Treatment-Resistant Depression in the 21st Century: A Scoping Review of Psychedelics and Neuromodulation in Transforming CarePremier Journal of Neuroscience · 2026-05-11 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-06-01